Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $1.98
- Average 1Y price target
- $12.00+506.06%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B3
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 1 | $12.00 |
| All time | 2 | $6.63 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 13, 2026 | Canaccord Genuity | maintain | Buy | Buy |
| Sep 24, 2025 | Canaccord Genuity | maintain | Buy | Buy |
| May 8, 2025 | Chardan Capital | downgrade | Buy | Neutral |
| Mar 20, 2025 | Chardan Capital | maintain | Buy | Buy |
| Mar 14, 2025 | Goldman Sachs | maintain | Sell | Sell |
| Nov 14, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Nov 13, 2024 | Chardan Capital | maintain | Buy | Buy |
| Oct 24, 2024 | JP Morgan | downgrade | Neutral | Underweight |
| Sep 13, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Aug 14, 2024 | Chardan Capital | maintain | Buy | Buy |
| Aug 14, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Jun 7, 2024 | Oppenheimer | downgrade | Outperform | Perform |
| Jun 7, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| May 9, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| May 8, 2024 | Chardan Capital | maintain | Buy | Buy |
| Mar 6, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Mar 6, 2024 | Chardan Capital | maintain | Buy | Buy |
| Jan 16, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Nov 3, 2023 | Goldman Sachs | maintain | Sell | Sell |
| Apr 28, 2023 | Chardan Capital | maintain | Buy | Buy |
| Apr 21, 2023 | JP Morgan | maintain | Neutral | Neutral |
| Mar 21, 2023 | Canaccord Genuity | maintain | Buy | Buy |
| Mar 8, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 8, 2023 | Chardan Capital | maintain | Buy | Buy |
| Mar 8, 2023 | Canaccord Genuity | maintain | Buy | Buy |
| Feb 8, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 7, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| May 23, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 23, 2021 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 23, 2021 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jul 23, 2021 | Goldman Sachs | downgrade | Neutral | Sell |
| Jul 23, 2021 | Chardan Capital | maintain | Buy | Buy |
| Jul 23, 2021 | Canaccord Genuity | maintain | Buy | Buy |
| May 5, 2021 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 5, 2021 | Chardan Capital | upgrade | Neutral | Buy |
| Dec 23, 2020 | JMP Securities | maintain | Market Perform | Perform |
| Sep 21, 2020 | Canaccord Genuity | maintain | Buy | Buy |
| Sep 18, 2020 | Chardan Capital | downgrade | Buy | Neutral |
| Aug 18, 2020 | Piper Sandler | maintain | Overweight | Overweight |
| Aug 11, 2020 | Jefferies | upgrade | Hold | Buy |